|
22 Mar 2007 |
Phase II/III pivotal study with trifunctional antibody removab(R) shows encouraging results in malignant ascites from various cancers
|
|
22 Mar 2007 |
Emergent BioSolutions Files Investigational New Drug Application With FDA for Pivotal Anthrax Immune Globulin Clinical Trial
|
|
21 Mar 2007 |
Pain Therapeutics Cleared to Initiate Phase I Study in Metastatic Melanoma
|
|
17 Mar 2007 |
FDA Approves Alexion's Soliris(TM) for All Patients With PNH
|
|
17 Mar 2007 |
Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
|
|
17 Mar 2007 |
Genmab in Research Cooperation with the Dahanca-Group
|
|
13 Mar 2007 |
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
|
|
13 Mar 2007 |
Symphogen and Biovitrum Initiate Phase 1 Clinical Trial with The First Recombinant Polyclonal Antibody to Enter Clinical Evaluation
|
|
13 Mar 2007 |
TopoTarget Executes Its Licensing Option for the Development of Zemab for Breast Cancer
|
|
13 Mar 2007 |
Protherics to receive £10 million milestone from AstraZeneca
|
|
13 Mar 2007 |
New Insights Into Novel Mechanisms of Action of Genmab's HuMax-EGFr
|
|
08 Mar 2007 |
MAT Biopharma Announced Today the Initiation of the Phase I/II Escalating Dose of Ferritarg P(R)
|
|
07 Mar 2007 |
Kyowa Hakko Kogyo Co., Ltd. Licenses its in-house developed antibody KW-2871 targeting malignant melanoma to Life Science Pharmaceuticals in the US.
|
|
01 Mar 2007 |
XOMA and Takeda Expand Collaboration for Therapeutic Antibody Discovery and Development
|
|
28 Feb 2007 |
Cytogen Announces Initiation of Phase 1 Trial for Radiolabeled Antibody for the Treatment of Hormone-Refractory Prostate Cancer
|
|
28 Feb 2007 |
Vaccinex Announces Antibody Development And Commercialization Alliance In Multiple Sclerosis And Oncology
|
|
28 Feb 2007 |
EvoGenix and Vegenics announce collaboration
|
|
28 Feb 2007 |
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
|
|
27 Feb 2007 |
Positive recommendation for Avastin use in advanced or recurrent colorectal cancer in Japan
|
|
24 Feb 2007 |
Avastin receives positive opinion in Europe for first-line treatment of women with metastatic breast cancer
|
|
23 Feb 2007 |
Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis
|
|
23 Feb 2007 |
New phase III study confirms positive outcome of Avastin in patients with advanced lung cancer
|
|
23 Feb 2007 |
Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
|
|
15 Feb 2007 |
Viventia Biotech provides update on cancer antibody clinical development programs
|
|
15 Feb 2007 |
Peregrine Pharmaceuticals Reports Positive Phase Ib Results for its Targeted Immunotherapy Bavituximab in Chronic Hepatitis C Infection
|
